Showing 1 - 7 results of 7 for search 'Keisuke Yokohama', query time: 0.03s
Refine Results
-
1
Hepatectomy and liver regeneration in the results of treatment of colorectal liver metastasis by Yoshihiro Inoue, Masatsugu Ishii, Keisuke Yokohama, Hideko Ohama, Yusuke Tsuchimoto, Tetsuji Terazawa, Akira Asai, Shinya Fukunishi, Kazuhide Higuchi, Kazuhisa Uchiyama
Published 2020-10-01
Article -
2
Diabetes mellitus does not influence results of hepatectomy in hepatocellular carcinoma: case control study by Yoshihiro Inoue, Yusuke Suzuki, Keisuke Yokohama, Hideko Ohama, Yusuke Tsuchimoto, Akira Asai, Shinya Fukunishi, Fumiharu Kimura, Kazuhide Higuchi, Kazuhisa Uchiyama
Published 2021-01-01
Article -
3
Efficacy and safety of laparoscopic hepatectomy for hepatocellular carcinoma comorbid with cirrhosis by Yoshihiro Inoue, Keisuke Yokohama, Hideko Ohama, Yusuke Tsuchimoto, Tetsuji Terazawa, Akira Asai, Shinya Fukunishi, Junji Okuda, Kazuhide Higuchi, Kazuhisa Uchiyama
Published 2020-09-01
Article -
4
Accurate SARC-F Score in Patients with Liver Disease by Masahiro Matsui, Akira Asai, Kosuke Ushiro, Saori Onishi, Tomohiro Nishikawa, Keisuke Yokohama, Hideko Ohama, Yusuke Tsuchimoto, Soo Ki Kim, Hiroki Nishikawa
Published 2023-06-01
Article -
5
Effects of Oral L-Carnitine on Liver Functions after Transarterial Chemoembolization in Intermediate-Stage HCC Patients by Abeer Hassan, Yasuhiro Tsuda, Akira Asai, Keisuke Yokohama, Ken Nakamura, Tetsuya Sujishi, Hideko Ohama, Yusuke Tsuchimoto, Shinya Fukunishi, Usama M. Abdelaal, Usama A. Arafa, Ali T. Hassan, Ali M. Kassem, Kazuhide Higuchi
Published 2015-01-01
Article -
6
Comparing the impact of atezolizumab plus bevacizumab and lenvatinib on the liver function in hepatocellular carcinoma patients: A mixed‐effects regression model approach by Takeshi Hatanaka, Satoru Kakizaki, Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Keisuke Yokohama, Hiroki Nishikawa, Takashi Nishimura, Noritomo Shimada, Kazuhito Kawata, Hisashi Kosaka, Atsushi Naganuma, Yutaka Yata, Hideko Ohama, Hidekatsu Kuroda, Kazunari Tanaka, Takaaki Tanaka, Fujimasa Tada, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Masatoshi Kudo, Takashi Kumada, the Real‐life Practice Experts for HCC (RELPEC) Study Group, and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan)
Published 2023-12-01
Article -
7
Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma by Hideko Ohama, Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Takeshi Hatanaka, Joji Tani, Koichi Takaguchi, Masanori Atsukawa, Ei Itobayashi, Takashi Nishimura, Kunihiko Tsuji, Kazuto Tajiri, Toru Ishikawa, Satoshi Yasuda, Hidenori Toyoda, Shinya Fukunishi, Chikara Ogawa, Satoru Kakizaki, Noritomo Shimada, Atsushi Naganuma, Kazuhito Kawata, Hisashi Kosaka, Hidekatsu Kuroda, Tomomitsu Matono, Yutaka Yata, Hironori Ochi, Fujimasa Tada, Kazuhiro Nouso, Asahiro Morishita, Norio Itokawa, Tomomi Okubo, Taeang Arai, Akemi Tsutsui, Takuya Nagano, Keisuke Yokohama, Hiroki Nishikawa, Michitaka Imai, Yohei Koizumi, Shinichiro Nakamura, Hiroko Iijima, Masaki Kaibori, Yoichi Hiasa, Takashi Kumada, Representing the Real‐life Practice Experts for HCC Study Group with Hepatocellular Carcinoma experts from 48 clinics in Japan (RELPEC/HCC 48 Group)
Published 2024-04-01
Article